Keith Katherine M, Castle Joshua P, Abed Varag, Wager Susan G, Patel Mit, Gaudiani Michael A, Yedulla Nikhil R, Makhni Eric C
Department of Orthopaedic Surgery, Henry Ford Health System, Detroit, MI USA.
JSES Int. 2023 Jul 14;7(6):2337-2343. doi: 10.1016/j.jseint.2023.06.014. eCollection 2023 Nov.
Efficacy of nonoperative treatment for rotator cuff tears has been debated, especially for full-thickness tears. The purpose of this study was to a) define the minimal clinically important difference (MCID) of nonoperative treatment with regard to Patient-Reported Outcomes Measurement Information System (PROMIS) pain interference (PI) and upper extremity (UE), and b) determine the proportion of patients with both partial and full-thickness tears (PTRCT, FTRCT) who achieve this improvement following initial nonoperative treatment. We hypothesized that >75% of PTRCT and FTRTC patients would achieve MCID for PROMIS PI and UE.
We performed a retrospective cohort study evaluating nonoperatively managed patients with image-confirmed PTRCT and FTRCT. Treatment modalities and follow-up PROMIS scores at least 6 months after their initial visit were recorded. Using a distribution technique, MCID was calculated.
A total of 111 FTRCT and 68 PTRCT patients were included with at least 6 months of follow-up. At 6 months from initial presentation, the MCID for PROMIS UE was 3.75 and 3.95 for FTRCT and PTRCT patients, respectively. For PROMIS PI, the MCID was 3.35 and 3.90 for FTRCT and PTRCT, respectively. In total, 41% of FTRCT and 41% of PTRCT achieved MCID for PROMIS UE. Thirty-four percent of FTRCT and 35% of PTRCT achieved MCID for PROMIS PI.
The majority of patients undergoing nonoperative treatment for supraspinatus/infraspinatus rotator cuff tears did not achieve MCID at 6 months for PROMIS PI (34% for FTRCT and 35% for PTRCT) or UE (41% for FTRCT and 41% for PTRCT).
肩袖撕裂的非手术治疗效果一直存在争议,尤其是对于全层撕裂。本研究的目的是:a)确定非手术治疗在患者报告结局测量信息系统(PROMIS)疼痛干扰(PI)和上肢(UE)方面的最小临床重要差异(MCID);b)确定部分和全层撕裂(PTRCT、FTRCT)患者在初始非手术治疗后达到这种改善的比例。我们假设超过75%的PTRCT和FTRTC患者在PROMIS PI和UE方面将达到MCID。
我们进行了一项回顾性队列研究,评估经影像学证实为PTRCT和FTRCT且接受非手术治疗的患者。记录治疗方式以及初次就诊至少6个月后的随访PROMIS评分。采用分布技术计算MCID。
总共纳入了111例FTRCT患者和68例PTRCT患者,且至少随访6个月。从初次就诊起6个月时,FTRCT和PTRCT患者的PROMIS UE的MCID分别为3.75和3.95。对于PROMIS PI,FTRCT和PTRCT的MCID分别为3.35和3.90。总体而言,41%的FTRCT患者和41%的PTRCT患者在PROMIS UE方面达到MCID。34%的FTRCT患者和35%的PTRCT患者在PROMIS PI方面达到MCID。
大多数接受非手术治疗的冈上肌/冈下肌肩袖撕裂患者在6个月时在PROMIS PI(FTRCT为34%,PTRCT为35%)或UE(FTRCT为41%,PTRCT为41%)方面未达到MCID。